Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Drummond

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Method without madnessMichael Drummond
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 24, 2005
Taking clinical trials to taskMichael Drummond
Lakartidningen|January 11, 2007
[High class of Swedish health economics seen from the international point of view. Continuous progress demands economical and political support according to an evaluation]Michael Drummond
Journal of Health Politics, Policy and Law|August 27, 2013
Twenty years of using economic evaluations for drug reimbursement decisions: what has been achieved?Michael Drummond
The Journal of Rheumatology. Supplement|January 10, 2004
Prioritizing investments in health: can we assess potential value for money?Michael Drummond
Value in Health Regional Issues|April 29, 2018
Future Prospects for Pharmacoeconomics and Outcomes Research in the Emerging RegionsMichael Drummond
Health Economics, Policy, and Law|July 19, 2008
NICE: a nightmare worth having?Michael Drummond
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
Evidence for coverage decisions: the need for a reality checkMichael Drummond
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 19, 2015
When do performance-based risk-sharing arrangements make sense?Michael Drummond
Applied Health Economics and Health Policy|November 19, 2003
Should commercial-in-confidence data be used by decision makers when making assessments of cost-effectiveness?Michael Drummond
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Method without madnessMichael Drummond
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 24, 2005
Taking clinical trials to taskMichael Drummond
Lakartidningen|January 11, 2007
[High class of Swedish health economics seen from the international point of view. Continuous progress demands economical and political support according to an evaluation]Michael Drummond
Journal of Health Politics, Policy and Law|August 27, 2013
Twenty years of using economic evaluations for drug reimbursement decisions: what has been achieved?Michael Drummond
The Journal of Rheumatology. Supplement|January 10, 2004
Prioritizing investments in health: can we assess potential value for money?Michael Drummond
Value in Health Regional Issues|April 29, 2018
Future Prospects for Pharmacoeconomics and Outcomes Research in the Emerging RegionsMichael Drummond
Health Economics, Policy, and Law|July 19, 2008
NICE: a nightmare worth having?Michael Drummond
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
Evidence for coverage decisions: the need for a reality checkMichael Drummond
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 19, 2015
When do performance-based risk-sharing arrangements make sense?Michael Drummond
Applied Health Economics and Health Policy|November 19, 2003
Should commercial-in-confidence data be used by decision makers when making assessments of cost-effectiveness?Michael Drummond
Pageof 20